Vulvovaginal myeloid sarcoma with massive pelvic floor infiltration: A case report and review of literature

doi:10.12998/wjcc.v10.i23.8312

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 23

This Article

(178)

(185)

(0)

(13)

(2)

(4827)

(3)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Case Report

World J Clin Cases. Aug 16, 2022; 10(23): 8312-8322
Published online Aug 16, 2022. doi: 10.12998/wjcc.v10.i23.8312

Full Size Figure Download Figure

Figure 4 One year after complete remission, pelvic magnetic resonance imaging shows no sign of tumour recurrence on either the vagina (orange arrow in A) or the pelvic floor (B).

Citation: Wang JX, Zhang H, Ning G, Bao L. Vulvovaginal myeloid sarcoma with massive pelvic floor infiltration: A case report and review of literature. World J Clin Cases 2022; 10(23): 8312-8322
URL: https://www.wjgnet.com/2307-8960/full/v10/i23/8312.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i23.8312

Wang JX, Zhang H, Ning G, Bao L. Vulvovaginal myeloid sarcoma with massive pelvic floor infiltration: A case report and review of literature. World J Clin Cases 2022; 10(23): 8312-8322 [PMID: 36159511 DOI: 10.12998/wjcc.v10.i23.8312]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.